Skip to main content
SpringerLink
Log in

Epidemiology of Asthma Mortality

  • Chapter
Allergy Frontiers: Epigenetics, Allergens and Risk Factors

Part of the book series: Allergy Frontiers ((ALLERGY,volume 1))

  • 1119 Accesses

In order to interpret data on long-term time trends in asthma mortality, it is necessary to firstly review the key issues of the accuracy of death certification, disease classification and diagnostic fashion. As the diagnosis of asthma as the cause of death is firmly established in the 5–34-year age group [1–6], long-term trends in asthma mortality within countries and comparisons between countries are normally confined to this age group. Although most deaths occur in the older age group, the accuracy of asthma as the cause of death declines with increasing age due to confounding with other respiratory disorders such as chronic obstructive pulmonary disease (COPD) or the presence of intercurrent medical conditions.

Changes in disease classification coding are also relevant, with the International Classification of Diseases (ICD) implementing major revisions in the coding of asthma. The ICD revisions occur about every 10 years, usually involving the manner in which deaths due to asthma and bronchitis are coded. These revisions usually have minimal effect on the coding in the 5–34-year age group [7–11].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. British Thoracic Association, BTA Research Committee (1984) Accuracy of death certificates in bronchial asthma. Thorax 39:505–509.

    Google Scholar 

  2. Sears MR, Rea HH, de Boer G, Beaglehole R, Gillies AJ, Holst PE, O'Donnell T V, Rothwell RP (1986) Accuracy of certification of deaths due to asthma: a national study. Am J Epidemol 124:1004–1011.

    CAS  Google Scholar 

  3. Sidenius KE, Munch EP, Madsen F, Lange P, Viskum K, Soes-Petersen U (2000) Accuracy of recorded asthma deaths in Denmark in a 12-months period in 1994/95. Respir Med 94:373–377.

    Article  PubMed  CAS  Google Scholar 

  4. Sirken MG, Rosenberg HM, Chevarley FM, Curtin LR (1987) The quality of cause-of-death statistics. Am J Pub Health 77:137–139.

    Article  CAS  Google Scholar 

  5. Jenkins M, Rubinfeld A, Robertson C, Bowes G (1992) Accuracy of asthma death statistics in Australia. Aust J Public Health 16:427–429.

    PubMed  CAS  Google Scholar 

  6. Hunt LW, Silverstein MD, Reed CE, O'Connell EJ, O'Fallon WM, Yunginger JW (1993) Accuracy of the death certificate in a population-bases study of asthmatic patients. JAMA 259:1947–1952.

    Article  Google Scholar 

  7. Beasley R, Smith K, Pearce N, Crane J, Burgess C, Culling C (1990) Trends in asthma mortality in New Zealand, 1908–1986. Med J Aust 152:570–573.

    PubMed  CAS  Google Scholar 

  8. Jackson R (1993) A century of asthma mortality. In: Beasley R, Pearce NE (eds) The role of beat agonist therapy in asthma mortality.CRC Press, New York, pp 29–47.

    Google Scholar 

  9. Jackson R, Sears MR, Beaglehole R, Rea HH (1988) International trends in asthma mortality: 1970 to 1985. Chest 94:914–918.

    Article  PubMed  CAS  Google Scholar 

  10. Dobbin CJ, Miller J, van der Hoek R, Baker DF, Cumming R, Marks GB (2004) The effects of age, death period and birth cohort on asthma mortality rates in Australia. Int J Tuberc Lung Dis 8:1429–1436.

    PubMed  CAS  Google Scholar 

  11. Weiss KB, Gergen PJ, Wagener DK (1993) Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and mortality. Ann Rev Publ Health 14:491–513.

    CAS  Google Scholar 

  12. Speizer FE, Doll R (1968) A century of asthma deaths in young people. Br Med J 3:245–246.

    PubMed  CAS  Google Scholar 

  13. Burney PGJ (1989) The effect of death certification practice on recorded national asthma mortality rates. Revue d'Epidemiologie et de Sante Publique 37:385–389.

    PubMed  CAS  Google Scholar 

  14. Kelson MC, Heller RF (1983) The effect of death certification and coding practices on observed differences in respiratory disease mortality in 8 EEC. countries. Revue d'Epidemiologie et de Sante Publique 31:423–432.

    PubMed  CAS  Google Scholar 

  15. Osler W (1901) The principles and practice of medicine, 4th edn. Pentland, Edinburgh.

    Google Scholar 

  16. Beasley CRW, Pearce NE, Crane J (2000) Epidemiology of asthma mortality. In: Giembycz MA, O'Connor BJ (eds) Asthma: epidemiology, anti-inflammatory therapy and future trends. Birkhauser Verlag, Basel, pp 1–24.

    Google Scholar 

  17. Speizer FE, Doll R, Heaf P (1968) Observations on recent increase in mortality from asthma. Br Med J 1:335–339.

    PubMed  CAS  Google Scholar 

  18. Stolley PD (1972) Why the United States was spared an epidemic of deaths due to asthma. Am Rev Respir Dis 105:883–890.

    PubMed  CAS  Google Scholar 

  19. Inman WHW, Adelstein AM (1969) Rise and fall of asthma mortality in England and Wales in relation to use of pressurized aerosols. Lancet ii:279–285.

    Article  Google Scholar 

  20. Speizer FE, Doll R, Heaf P, Strang LB (1968) Investigation into use of drugs preceding death from asthma. Br Med J 1:339–343.

    PubMed  CAS  Google Scholar 

  21. Fraser PM, Speizer FE, Waters SD, Doll R, Mann NM (1971) The circumstances preceding death from asthma in young people in 1968 to 1969. Br J Dis Chest 652:71–84.

    Google Scholar 

  22. Collins JM, McDevitt DG, Shanks RG, Swanton JG (1969) The cardio-toxicity of isoprenaline during hypoxia. Br J Pharmacol 36:35–45.

    PubMed  CAS  Google Scholar 

  23. Lockett MF (1965) Dangerous effects of isoprenaline in myocardial failure. Lancet ii:104–106.

    Article  Google Scholar 

  24. Lowell FC, Curry JJ, Schiller IW (1949) A clinical and experimental study of isoprel in spontaneous and induced asthma. N Engl J Med 240:45–51.

    Article  CAS  Google Scholar 

  25. Keighley JF (1966) Iatrogenic asthma associated with adrenergic aerosols. Ann Int Med 65:985–995.

    PubMed  CAS  Google Scholar 

  26. van Metre TE (1969) Adverse effects of inhalation of excessive amounts of nebulised isoproterenol in status asthmaticus. J Allergy 43:101–113.

    Article  PubMed  Google Scholar 

  27. Stolley PD, Schinnar R (1978) Association between asthma mortality and isoproterenol aerosols: a review. Prev Med 7:319–338.

    Article  Google Scholar 

  28. Mitsui S (1986) Death from bronchial asthma in Japan. Sino-Jpn. J Allergol Immunol 3:249–257.

    Google Scholar 

  29. Venning GR (1983) Identification of adverse reactions to new drugs. 1. What have been the important adverse reactions since thalidomide? Br Med J 286:199–202.

    Article  CAS  Google Scholar 

  30. Pearce N, Hensley MJ (1998) Epidemiologic studies of beta-agonists and asthma deaths. Epidemiol Rev 20:173–186.

    PubMed  CAS  Google Scholar 

  31. Jackson RT, Beaglehole R, Rea HH, Sutherland DC (1982) Mortality from asthma: a new epidemic in New Zealand. Br Med J 285:771–774.

    CAS  Google Scholar 

  32. Crane J, Burgess C, Pearce N, Beasley R (1993) The β-agonist controversy: a perspective. Eur Respir Rev 3:475–482.

    Google Scholar 

  33. Mugge A, Posselt D, Reimer U, Schmitz W, Scholz H (1985) Effects of beta 2-adrenceptor agonist, fenoterol and salbutamol, on force of contraction in isolated human ventricular myocardium. Klin Wochenschr 63:26–31.

    Article  PubMed  CAS  Google Scholar 

  34. Wagner J, Reinhardt, Schumann HJ (1973) Comparison of the bronchodilator and cardiovascular actions of isoprenaline, Th 1165a, tertutaline and salbutamol in cats and isolated organ preparations. Res Exp Med 162:49–62.

    Article  Google Scholar 

  35. Bremner P, Siebers R, Crane J, Beasley R, Burgess C (1996) Partial vs full β-receptor agonism: A clinical study of inhaled albuterol and fenoterol. Chest 109:957–962.

    Article  PubMed  CAS  Google Scholar 

  36. Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R (1989) Prescribed fenoterol and death from asthma in New Zealand, 1981–83: A case control study. Lancet 1:917–922.

    Article  PubMed  CAS  Google Scholar 

  37. Pearce N, Grainger J, Atkinson M, Crane J, Burgess C, Culling C, Windom H, Beasley R (1990) Case—control study of prescribed fenoterol and death from asthma in New Zealand 1977–1981. Thorax 45:170–175.

    PubMed  CAS  Google Scholar 

  38. Grainger J, Woodman K, Pearce N, Crane J, Burgess C, Keane A, Beasley R (1991) Prescribed fenoterol and death from asthma in New Zealand, 1981–1987: A further case—control study. Thorax 46:105–111.

    PubMed  CAS  Google Scholar 

  39. Beasley R, Burgess C, Pearce N, Woodman K, Crane J (1994) Confounding by severity does not explain the association between fenoterol and asthma death. Clin Exp Allergy 24:660–668.

    Article  PubMed  CAS  Google Scholar 

  40. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS (1992) The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 326:501–506.

    PubMed  CAS  Google Scholar 

  41. Suissa S, Ernst P, Boivin J-F, Horwitz RI, Habbick B, Cockroft D, Blais L, McNutt M, Buist AS, Spitzer WO (1994) A cohort analysis of excess mortality in asthma and the use of inhaled β-agonists. Am J Respir Crit Care Med 149:604–610.

    PubMed  CAS  Google Scholar 

  42. Matsui T (1996) Asthma deaths and β2-agonists. Current advances in paediatric allergy and clinical epidemiology. In: K Shimomiya (ed). Selected proceedings from the 32nd annual meeting of the Japanese Society of Paediatric Allergy and Clinical Immunology. Churchill Livingstone, Tokyo, pp 161–164.

    Google Scholar 

  43. Beasley R, Nishima S, Pearce N, Crane J (1998) β-agonists therapy and asthma mortality in Japan. Lancet 351: 1406–1407.

    Article  PubMed  CAS  Google Scholar 

  44. Criée C-P, Quast CH, Ludtke R, Laier-Groeneveld G, Huttemann U (1993) Use of beta agonists and mortality in patients with stable COPD. Eur Respir J 6:426S (abstract).

    Google Scholar 

  45. van der Merwe L, de Klerk A, Kidd M, Bardin PG, van Schalkwyk EM (2006) Case—control study of severe life threatening asthma (SLTA) in a developing community. Thorax 61:756–760.

    Article  PubMed  Google Scholar 

  46. Pearce N, Beasley R, Crane J, Burgess C, Jackson R (1995) End of the New Zealand mortality epidemic. Lancet 345:41–44.

    Article  PubMed  CAS  Google Scholar 

  47. Sears MR (1991) Worldwide trends in asthma mortality. Bull Int Union Tuberc Lung Dis 66:79–83.

    PubMed  CAS  Google Scholar 

  48. Pearce NE, Crane J (1993) Epidemiological methods for studying the role of beta receptor agonist therapy in asthma mortality. In: Beasley R, Pearce NE (eds). The role of beta receptor agonist therapy in asthma mortality. CRC Press, New York, pp 68–83.

    Google Scholar 

  49. Barrett TE, Strom BL (1995) Inhaled beta-adrenergic receptor agonists in asthma: more harm than good? Am J Respir Crit Care Med 151:574–577.

    PubMed  CAS  Google Scholar 

  50. Gibson P, Henry D, Francis L, Cruickshank D, Dupen F, Higginbotham N, Henry R, Sutherland D (1993) Association between availability of non-prescription beta 2-agonist inhalers and undertreatment of asthma. Br Med J 306:1514–1518.

    CAS  Google Scholar 

  51. Pearce N, Crane J, Beasley R (1997) Isoprenaline, fenoterol and asthma deaths in Japan. Jpn Soc Pediatr Allergy Clin Immunol 11:307–316.

    Google Scholar 

  52. Beasley R, Crane J, Lai CKW, Pearce N (2000) Prevalence and etiology of asthma. J Allergy Clin Immunol 105:S466–S472.

    Article  PubMed  CAS  Google Scholar 

  53. Kaur B, Butland B (1997) Asthma mortality is falling in most age groups in Scotland. BMJ 315:1014.

    PubMed  CAS  Google Scholar 

  54. Wever-Hess J, Wever AMJ (1997) Asthma statistics in the Netherlands 1980–94. Respir Med 91:417–422.

    Article  PubMed  CAS  Google Scholar 

  55. Baluga JC, Sueta A, Ceni M (2001) Asthma mortality in Uruguay, 1984–1998. Ann Allergy Asthma Immunol 87:124–128.

    Article  PubMed  CAS  Google Scholar 

  56. Neffen H, Baena-Cagnani C, Passalacqua G, Canonica GW, Rocco D (2006) Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990–1999). Resp Med 100:1431–1435.

    Article  Google Scholar 

  57. Anderson HR, Gupta R, Strachan DP, Limb ES (2007) 50 years of asthma: UK trends from 1955 to 2004. Thorax 62:85–90

    Article  PubMed  Google Scholar 

  58. Zar HJ, Stickells D, Toerien A, Wilson D, Klein M, Bateman ED (2001) Changes in fatal and near-fatal asthma in an urban area of South Africa from 1980–1997. Eur Respir J 18:33–37.

    Article  PubMed  CAS  Google Scholar 

  59. Goldman M, Rachmiel M, Gendler L, Kats Y (2000) Decrease in asthma mortality rate in Israel from 1991–1995: is it related to increased use of inhaled corticosteroids? J Allergy Clin Immunol 105:71–74.

    Article  PubMed  CAS  Google Scholar 

  60. Lim DL, Ma S, Wang XS, Cutter J, Chew SK (2006) Trends in sales of inhaled corticosteroids and asthma outcomes in Singapore. Thorax 61:362–365.

    Article  PubMed  CAS  Google Scholar 

  61. Fabre Ortiz DE, Cabrera Perez JF, Armas Perez L, Gonzales Ochoa E (1997) Asthma mortality in Cuba during 1972–1993. Allergol Immunopathol 25:289–292.

    CAS  Google Scholar 

  62. Markov A (1995) The problem of asthma in the Ukraine. Allergy Proc 16: 269–273.

    Article  PubMed  CAS  Google Scholar 

  63. Oganov RG, Maslennikova GYa (1999) Asthma mortality in Russia between 1980 and 1989. Eur Respir J 13:287–289.

    Article  PubMed  CAS  Google Scholar 

  64. CDC Compressed mortality data: underlying causes of death. http://wonder.cdc.gov/mort-SQL.htm. Accessed June 2007.

  65. Suissa S. Ernst P, Benayoun S, Maltzan M, Cai B (2000) Low-dose inhaled corticosteroids and the prevention of death from asthma. New Engl J Med 343:332–336.

    Article  PubMed  CAS  Google Scholar 

  66. Sin DD, Tu JV (2001) Inhaled corticosteroid therapy reduces the risk of rehospitalisation and all-cause mortality in elderly asthmatics. Eur Respir J 17:380–385.

    Article  PubMed  CAS  Google Scholar 

  67. Lanes SF, Garcia Rodriguez LA, Huerta C (2002) Respiratory medications and risk of asthma death. Thorax 57:683–686.

    Article  PubMed  CAS  Google Scholar 

  68. Eisner MD, Lieu TA, Chi F, Capra AM, Mendoza GR, Selby JV, Blanc PD (2001) Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma. Eur Respir J; 17:233–240.

    Article  PubMed  CAS  Google Scholar 

  69. Ernst P, Spitzer WO, Suissa S, Cockcroft D, Habbick B, Horwitz RI, Boivin J-F, McNutt M, Buist AS (1992) Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 268:3462–3464.

    Article  PubMed  CAS  Google Scholar 

  70. Holt S, Suder A, Weatherall M, Cheng S, Beasley R (2001) Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ 323:253–256.

    Article  PubMed  CAS  Google Scholar 

  71. Masoli M, Holt S, Weatherall M, Shirtcliffe P, Beasley R (2006) Inhaled corticosteroid therapy in the management of asthma in adults. In: Li JT (ed) The pharmacotherapy of asthma, vol 212. Taylor & Francis Group, New York, pp 83–115.

    Google Scholar 

  72. Gupta R, Anderson HR, Strachan DP, Maier W, Watson L (2005) International trends in admissions and drug sales for asthma. Int J Tuberc Lung Dis 12:138–145.

    Google Scholar 

  73. Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA on behalf of the Working Group of the Asthma Programme in Finland 1994–2004 (2001) Asthma programme in Finland: a community problem needs community solutions. Thorax 56:806–814.

    Article  PubMed  CAS  Google Scholar 

  74. Kumana CR, Kou M, Lauder IJ, Ip MSM, Lam WK (2001) Increasing use of inhaled steroids associated with declining asthma mortality. J Asthma 38:161–167.

    Article  PubMed  CAS  Google Scholar 

  75. Melissinos CG, Gourgoulianis K, Adamidis SC (1995) Inhaled drug consumption and asthma mortality in Greece. Chest 107:1771–1772.

    Article  PubMed  CAS  Google Scholar 

  76. AIHW Australian Centre for Asthma Monitoring (2005) Asthma in Australia. AIHW Asthma Series 2. AIHW cat. no. ACM 6. AIHW, Canberra.

    Google Scholar 

  77. Masoli M, Fabian D, Holt S, Beasley R (2004) Global burden of asthma. Global Initiative for Asthma (GINA). www.ginasthma.com. Accessed June 2007

  78. Burney PGJ, Luczynska C, Chinn S, Jarvis D (1994) The European Community Respiratory Health Survey. Eur Respir J 7:954–960.

    PubMed  CAS  Google Scholar 

  79. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Mitchell EA, Pearce N, Sibbald B, Stewart AW, Strachan D, Weiland SK, Williams HC (1995) International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J 8:483–491.

    Article  PubMed  CAS  Google Scholar 

  80. Ait-Khaled N, Auregan G, Camara LM, Dagli E, Djankine K, Keita B, Ky C, Mahl S, Ngoran K, Pham DL, Sow O, Yousser M, Zidouni N, Enarson DA (2000) Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int J Tuberc Lung Dis 4:268–271.

    PubMed  CAS  Google Scholar 

  81. Watson JP, Lewis RA (1997) Is asthma treatment affordable in developing countries. Thorax 52:605–607.

    Article  PubMed  CAS  Google Scholar 

  82. Weiss KB, Wagener DK (1990) Changing patterns of asthma mortality: identifying populations at high risk. JAMA 264:1683–1687.

    Article  PubMed  CAS  Google Scholar 

  83. Marder D, Targonski P, Orris P, Persky V, Addington W (1992) Effect of racial and socioeconomic factors on asthma mortality in Chicago. Chest 101(6 Suppl):426S–429S.

    Article  PubMed  CAS  Google Scholar 

  84. Gupta RS, Carrion-Carire V, Weiss KB (2006) The widening black/white gap in asthma hospitalizations and mortality. J Allergy Clin Immunol 117:351–358.

    Article  PubMed  Google Scholar 

  85. Ng TP, Tan WC (1999) Temporal trends and ethnic variations in asthma mortality in Singapore, 1976–1995. Thorax 54:990–994.

    PubMed  CAS  Google Scholar 

  86. Anto JM, Sunyer J (1986) Asthma Collaborative Group of Barcelona. A point source asthma outbreak. Lancet i:900–903.

    Article  Google Scholar 

  87. Kwon HJ, Cho SH, Chun Y, Lagarde F, Pershagen G (2002) Effects of the Asian dust events on daily mortality in Seoul, Korea. Environ Res 90:1–5.

    Article  PubMed  CAS  Google Scholar 

  88. Vijayan VK, Kuppurao KV (1993) Early clinical, pulmonary function and blood gas studies in victims of Bhopal tragedy. Biomed 13:36–42.

    Google Scholar 

  89. Misra NP, Pathak R, Gaur KJBS et al. (1987) Clinical profile of gas leak victims in acute phase after Bhopal episode. Ind J Med Res 86(Suppl):11–19.

    Google Scholar 

  90. Salinas M, Vega J (1995) The effect of outdoor air pollution on mortality risk: an ecological study from Santiago, Chile. World Health Statist Quart 48:118–125.

    CAS  Google Scholar 

  91. Lang DM (1998) Atmospheric pollution contributing to fatal asthma. In: Sheffer AL (ed). Fatal asthma. Marcel Dekker, New York, pp 211–236.

    Google Scholar 

  92. Campbell MJ, Cogman GR, Holgate ST, Johnston SL (1997) Age specific trends in asthma mortality in England and Wales, 1983–95: results of an observational study. BMJ 314:1439–1441.

    PubMed  CAS  Google Scholar 

  93. Cadet B, Robine JM, Leibovici D (1994) Dynamic of asthma mortality in France: seasonal variation and peaking of mortality in 1985–87. Revue d ”Epidemiologique et de Sante Publique 42:103–118.

    CAS  Google Scholar 

  94. Kimbell-Dunn M, Pearce N, Beasley R (2000) Seasonal variation in asthma hospitalizations and death rates in New Zealand. Respirol 5:241–246.

    Article  CAS  Google Scholar 

  95. Weiss KB (1990) Seasonal trends in US asthma hospitalizations and mortality. JAMA 263:2323–2328.

    Article  PubMed  CAS  Google Scholar 

  96. O'Hallaren MT (1998) Seasonal variations in asthma mortality. In: Sheffer AL (ed). Fatal asthma. Marcel Dekker, New York, pp 397–410.

    Google Scholar 

  97. Ito Y, Tamakoshi A, Wakai K, Takagi K, Yamaki K, Ohno Y (2002) Trends in asthma mortality in Japan. J Asthma 39:633–639.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Research Institute of New Zealand, PO Box 10055, Wellington, 6143, New Zealand

    Richard Beasley, Meme Wijesinghe & Kyle Perrin

Authors
  1. Richard Beasley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meme Wijesinghe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kyle Perrin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, Japan

    Ruby Pawankar

  2. Childrens's Mercy Hospital & Clinic, 2401 Gillham RD, Kansas city, MO, USA

    Stephen T. Holgate

  3. Southampton General Hospital, University of Southampton, Tremona Road, Southampton, UK

    Lanny J. Rosenwasser

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer

About this chapter

Cite this chapter

Beasley, R., Wijesinghe, M., Perrin, K. (2009). Epidemiology of Asthma Mortality. In: Pawankar, R., Holgate, S.T., Rosenwasser, L.J. (eds) Allergy Frontiers: Epigenetics, Allergens and Risk Factors. Allergy Frontiers, vol 1. Springer, Tokyo. https://doi.org/10.1007/978-4-431-72802-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-72802-3_7

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-72801-6

  • Online ISBN: 978-4-431-72802-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation